
Can Alzheimer's Be Prevented? The Neuroscience of Aging and Memory Loss
In this episode of Longevity with David Rubenstein, we explore the cutting-edge neuroscience of aging and Alzheimer’s — from the first subtle signs of memory loss to breakthrough drugs that could slow or even prevent cognitive decline.
Rubenstein speaks with leading experts: Dr. Richard Isaacson, Dr. Maria Carrillo, Dr. Vivek Murthy, and Bloomberg’s Robert Langreth to uncover how science, lifestyle and technology are transforming our understanding of brain health. This episode also examines the economic impact of dementia, including the costs to patients, caregivers, and healthcare systems, and how pharmaceutical companies are investing in the next generation of Alzheimer’s treatments.
Chapters:
00:00:00 - The Complexity of the Human Brain
00:03:15 - Difference between Alzheimer's and Dementia
00:05:01 - Early Signs of Alzheimer's
00:06:26 - Dr. Alzheimer
00:08:16 - Risks for developing dementia
00:09:04 - What to do to prevent Alzheimer's
00:09:39 - U.S. POINTER Study
00:12:21 - Age and Gender Risk
00:13:00 - The Cost of Dementia in 2025
00:13:59 - Pharmaceuticals investing in Alzheimer treatments
00:14:22 - FDA approved drugs
00:15:02 - Blood tests to detect Alzheimer's
00:19:35 - What can people do today to prevent risk of Alzheimer's
00:20:20 - Brain healthy foods
00:22:53 - No cure for Alzheimer's yet, but can slow it down
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
/ @davidrubenstein
Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer
Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness
